Estimates Revisions THX Pharma Deutsche Boerse AG

Stocks

Real-time Estimate Cboe Europe 11:30:00 2026-09-10 EDT			5-day change	1st Jan Change
3.418 ^EUR	-2.06%		-16.11%	+69.25%

09-02	THX Pharma Partnership Seeks Regulatory Clearance for Late-stage Juvenile Batten Disease Drug Trial	MT
09-01	THX Pharma Submits Regulatory Applications To Initiate Phase 3 Clinical Trial Of Batten-1 In Juvenile Batten Disease	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	WUXI APPTEC CO., LTD.
	ARGENX SE
	INSMED INCORPORATED
	WUXI BIOLOGICS (CAYMAN) INC.
	BIONTECH SE
	GENMAB A/S
	PHARMAESSENTIA CORPORATION
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
	EXELIXIS, INC.
	Average
	Weighted average by Cap.